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Errata
In the article ‘‘p38 Mitogen-activated protein kinase inhibitor
protects the epidermis against the acute damaging effects
of ultraviolet irradiation by blocking apoptosis and inflam-
matory responses’’ by Hildesheim J, Awwad RT, Fornace AJ
Jr: J Invest Dermatol 122:497–502, 2004, there is an error in
Table I (‘‘Effect of the p38 MAPK inhibitor SB202190 on
UVR-induced sunburn cells’’). The two columns corre-
sponding to the average sunburn cells per cm in animals
treated either with or without SB202190 are inverted. The
left column should read ‘‘Without SB202190’’ and the right
column should read ‘‘With SB202190’’. The authors regret
the error.
The cover legend for the April 2004 issue of the Journal is
incorrect. Instead of ‘‘Gene therapy’’ the legend should have
read ‘‘Enzyme replacement therapy (right) clears capillary
globotriaosylceramide’’. The editor regrets the error.
Figure 1
STAT1, IRF-9, and IRF-7 proteins are
expressed in the nuclei of keratin-
ocytes. Immunohistochemical analy-
sis of STAT1 (upper panel ), IRF-9
(middle panel ) and IRF-7 (lower pan-
el ) proteins in healthy (NN, left row),
non-lesional (PN, middle row), and
lesional psoriatic (PP, right row) skin
biopsies. Scale bar¼ 100 mm.
In the article ‘‘In psoriasis lesio-
nal skin the type I interferon
signaling pathway is activated,
whereas interferon-a sensitivity
is unaltered’’ by van der Fits L,
van der Wel LI, Laman JD, Prens
EP, Verschuren MCM: J Invest
Dermatol 122:51–60, 2004, the
resolution of Fig 1 (p. 52) was
very low, making the differences
that are pointed out by the orig-
inal photo invisible in this re-
production. Therefore, in this
erratum, this figure is reprinted.
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